Group B Streptococcus neonatal invasive infections in Belgium, 2013-2016
peer reviewed ; Background Since 2003, intrapartum antimicrobialprophylaxis (IAP) based on a universal screening for group B streptococcus (GBS) colonization at 35-37 weeks’ gestation is recommended in Belgium. Following, a decrease in the incidence of early-onset disease (EOD) was observed whereas late onset disease (LOD) have not changed. We describe the clinical and bacteriological characteristics of GBS neonatal invasive infections reported to the Belgian National Reference Centre (NRC) for GBS from 2013 to mid 2016. Methods On a voluntary base, all laboratories located in Belgium are invi... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | conference paper |
Erscheinungsdatum: | 2018 |
Schlagwörter: | Group B streptococcus / Neonatal invasive disease / Belgium / Human health sciences / Pediatrics / Public health / health care sciences & services / Laboratory medicine & medical technology / Immunology & infectious disease / Sciences de la santé humaine / Pédiatrie / Santé publique / services médicaux & soins de santé / Médecine de laboratoire & technologie médicale / Immunologie & maladie infectieuse |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28940974 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://orbi.uliege.be/handle/2268/223201 |